Long Intergenic Noncoding RNAs: New Links in Cancer Progression
Howard Hughes Medical Institute · Stanford University
Indexed incrossrefpubmed
Abstract
The process of cancer metastasis involves a series of sequential and complex steps. Here we give a perspective on recent results regarding noncoding transcription in cancer progression, focusing on the emerging role of long intergenic noncoding RNAs (lincRNAs). LincRNAs target chromatin modification complexes or RNA-binding proteins to alter gene expression programs. Similarly to miRNAs, lincRNAs exhibit distinct gene expression patterns in primary tumors and metastases. We discuss how lincRNAs can be used for cancer diagnosis and prognosis and serve as potential therapeutic targets.
Citation impact
645
total citations
- FWCI
- 15.77
- Percentile
- 100%
- References
- 43
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Biology
- Intergenic region
- microRNA
- Non-coding RNA
- Chromatin
- Long non-coding RNA
- Metastasis
- Computational biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.